Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia.
about
First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemiaFirst-line stem cell transplantation from related donors compared to immunosuppressive treatment for acquired severe aplastic anaemiaCurrent concepts in the pathophysiology and treatment of aplastic anemiaEltrombopag for the treatment of aplastic anemia: current perspectivesClonal hematopoiesis in acquired aplastic anemiaCyclosporine-responsive thrombocytopenia in a patient with chloramphenicol-associated myelodysplastic syndrome.Immunosuppressive therapy for transplant-ineligible aplastic anemia patients.Unrelated donor stem cell transplantation in acquired severe aplastic anemia: a systematic review.High-dose cyclophosphamide for severe aplastic anemia: long-term follow-upProlonged cyclosporine administration after antithymocyte globulin delays but does not prevent relapse in severe aplastic anemia.Efforts to prevent and halt autoimmune beta cell destruction.Outcome of allogeneic hematopoietic cell transplantation from HLA-identical siblings for severe aplastic anemia in patients over 40 years of age.Relapse of aplastic anemia in children after immunosuppressive therapy: a report from the Japan Childhood Aplastic Anemia Study Group.Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donorsModerate-dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution.Recent advances in treatment of aplastic anemia.Aplastica anemia and viral hepatitisMolecular basis of clonal expansion of hematopoiesis in 2 patients with paroxysmal nocturnal hemoglobinuria (PNH).Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials NeMyelodysplastic syndrome evolving from aplastic anemia treated with immunosuppressive therapy: efficacy of hematopoietic stem cell transplantationHigh-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseasesSevere fatigue: could it be aplastic anemia?Natural history of paroxysmal nocturnal hemoglobinuria clones in patients presenting as aplastic anemiaEvaluation of angiogenesis and vascular endothelial growth factor expression in the bone marrow of patients with aplastic anemia.Clinical observations on intensive immunosuppressive therapy combined with umbilical cord blood support for the treatment of severe aplastic anemia.SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes.Clinical management of aplastic anemia.Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia.Safety and efficacy of indigenous equine antithymocyte globulin along with cyclosporine in subjects with acquired aplastic anemia.Immune dysregulation in myelodysplastic syndrome.Immunosuppressive therapy in patients with aplastic anemia: a single-center retrospective study.Long-term follow up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioningImpaired Autophagy in Adult Bone Marrow CD34+ Cells of Patients with Aplastic Anemia: Possible Pathogenic Significance.Model-Based Determination of Effective Blood Concentrations of Cyclosporine for Neutrophil Response in the Treatment of Severe Aplastic Anemia in Children.In vivo effects of horse and rabbit antithymocyte globulin in patients with severe aplastic anemia.Unexpected unrelated umbilical cord blood stem cell engraft in two patients with severe aplastic anemia that received immunosuppressive treatment: A case report and literature reviewHaematopoietic stem cell transplantation to treat aplastic anaemia.Aplastic anemia: pathophysiology and treatment.Evolving hematopoietic stem cell transplantation strategies in severe aplastic anemia.Clonal evolution and clinical significance of copy number neutral loss of heterozygosity of chromosome arm 6p in acquired aplastic anemia
P2860
Q24201108-DF4913BF-2381-4E74-8B4B-A8B63EDC9AA2Q24243326-D2248A5A-841B-4304-A677-B4759D45A836Q24685812-498F62BB-4635-4F4A-B234-761488269DDBQ28071710-16974967-1651-41D7-9C08-598ADFADAC42Q28079733-01315588-67E5-4315-BF05-2505FD3BC6DAQ33370159-4677EDA0-51D8-4821-B570-54795BB43A2DQ33419679-1052B08C-65D7-4E9B-9E77-923BCEF80B16Q33489272-C6A54738-8CB7-4219-ABBF-D46EEDF2A518Q33747331-C1AFFA66-EDB3-4A8A-A437-2DDBE49C76B5Q33820120-9830670B-D2FD-48E9-A635-8D6A01AEFA67Q34077363-A082883B-B554-4F8F-88CD-C7A6634ADDB1Q34108254-ED84ACB8-CC0C-496D-9499-0287F60772B5Q34172212-376C265B-7909-4229-A2D4-CE72CE825552Q34371142-7E72C2B4-464B-47BA-ACFB-B27AFCD98329Q34431435-1DFE10F2-569F-4AB2-AA51-C9D46173975BQ34451351-2BCE83E1-8E83-44B0-AECE-03DBAF57F11BQ34549277-91F7DF25-C78F-43D8-983A-06B951EAD64CQ34561626-B945C16F-AE00-413D-96EA-83B57880AB0EQ34645147-A2FBDADE-F038-49A0-9E87-A9AE93991B40Q34649014-D91E6D99-2F3A-433D-9782-0E4D326F928BQ34986999-FA0090C9-AFEF-42C5-9907-AACFD158C22BQ34989207-3C0ACF59-A88F-47D4-B207-09FFAEEB71E1Q35061800-7D48A85E-473B-41D1-9DB9-8E0ACFA0AEC8Q35070746-3B86F653-15E7-4D86-80B3-E4E73F79961BQ35081963-D6838031-73AF-4377-800F-F00B61DD8AA8Q35083258-A3B9341E-8D71-4177-A2E3-34F8BC841737Q35112372-3D0C6615-4B4E-4036-8C7A-899FB60D7DF1Q35193715-2BC1ECDD-F1C1-45D0-A580-10846F1D1D45Q35220764-7994DD12-529B-4E3F-BA45-7D5825EECFFBQ35567932-C637492D-E838-48F1-803B-25029DCFB662Q35602992-A8D809AB-DF2E-426E-8A26-974A87E79FCCQ35930597-7913AE94-83EF-4FFD-A141-262282D6B21FQ35941441-6EE933E7-8168-46C2-8287-7C4B518ACEADQ35967925-475C30AE-1DD9-4DB3-88AF-D5F5D40F7FA8Q36036288-479ED09D-47D2-4A7C-92CB-E3C70C6ECF48Q36081355-293B83E9-D212-4310-BD5A-1124E383B78FQ36150480-A3C08965-701B-418B-ADA6-036BEE7ED9EEQ36464602-4C430228-129A-4782-A3EA-46A5EB615731Q36497220-7A6EB8D3-8F80-4AC8-93BE-35D0DB43CAF0Q36535499-4FE97E66-8B20-4C04-9DAB-48682333F505
P2860
Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Antithymocyte globulin with or ...... treatments of aplastic anemia.
@en
Antithymocyte globulin with or ...... treatments of aplastic anemia.
@nl
type
label
Antithymocyte globulin with or ...... treatments of aplastic anemia.
@en
Antithymocyte globulin with or ...... treatments of aplastic anemia.
@nl
prefLabel
Antithymocyte globulin with or ...... treatments of aplastic anemia.
@en
Antithymocyte globulin with or ...... treatments of aplastic anemia.
@nl
P2093
P1433
P1476
Antithymocyte globulin with or ...... treatments of aplastic anemia.
@en
P2093
German Aplastic Anemia Study Group
Hermann Heimpel
Hubert Schrezenmeier
Joachim P Kaltwasser
Norbert Frickhofen
P304
P356
10.1182/BLOOD-2002-04-1134
P407
P577
2002-10-10T00:00:00Z